DEFLAZACORT 6MG TAB
It belongs to a group of medicines called steroids. It is used for the treatment of various diseases and conditions such as inflammatory conditions and autoimmune conditions.
Deflazacort 6 mg is a corticosteroid medicine used to reduce inflammation and modify immune-system activity. Depending on the product and country, deflazacort may be prescribed for conditions requiring systemic corticosteroid treatment, including Duchenne muscular dystrophy (DMD).
Deflazacort 6 mg contains deflazacort, a synthetic glucocorticoid corticosteroid. It is converted in the body to an active metabolite that acts on glucocorticoid receptors.
Deflazacort reduces inflammation and suppresses certain immune responses. Its approved uses and age indications can differ between products and countries.
Deflazacort 6 mg may be prescribed to:
Treat Duchenne muscular dystrophy (DMD), where approved for the relevant age group
Treat certain inflammatory, autoimmune, allergic, or other conditions that require systemic corticosteroid therapy, depending on local product approval
The appropriate treatment and dose should be determined by a healthcare professional based on the condition being treated and the individual clinical circumstances.
Deflazacort is converted to an active metabolite that binds to glucocorticoid receptors. This produces anti-inflammatory and immunosuppressive effects, helping reduce inflammation and excessive immune activity.
Take Deflazacort exactly as prescribed by your healthcare professional.
Follow the prescribed dose and schedule carefully.
Deflazacort tablets may generally be taken with or without food.
Do not take deflazacort with grapefruit juice unless your healthcare professional specifically advises otherwise.
Swallow the tablet as directed by your healthcare professional. Some tablet products may also be crushed and mixed with soft food; follow the instructions for your specific product.
Do not stop long-term or prolonged corticosteroid treatment suddenly. The dose may need to be reduced gradually under medical supervision.
Tell your doctor or pharmacist about your medical history and all medicines, supplements, and herbal products you use before taking deflazacort.
Use particular caution if you have:
An active or recent infection
Diabetes or problems with blood glucose
High blood pressure, heart failure, or kidney problems
A history of stomach or intestinal ulcers or other significant gastrointestinal disease
Osteoporosis or other bone problems
Eye conditions such as glaucoma or cataracts
A history of significant mood or psychiatric problems
Conditions requiring vaccination, particularly if a live or live-attenuated vaccine is planned
Important interaction categories include medicines that affect CYP3A4 enzymes, certain neuromuscular blocking medicines, and some medicines or products that can alter the effects or exposure of deflazacort. Grapefruit juice can also interact with deflazacort.
Check possible interactions with your doctor or pharmacist before starting or changing any medicine.
If you are pregnant, planning pregnancy, or breastfeeding, speak with your doctor before using deflazacort. Corticosteroids during pregnancy should be used when the potential benefit justifies the potential risk, and there are limited human data specifically for deflazacort.
Systemically administered corticosteroids can pass into breast milk and may affect a breastfed infant. Your doctor will consider the need for treatment and the potential effects on the infant when deciding whether deflazacort is appropriate during breastfeeding.
Like all medicines, Deflazacort can cause side effects, although not everyone experiences them.
Common or important side effects may include:
Increased appetite or weight gain
Changes in body appearance associated with corticosteroid treatment
Increased susceptibility to infections
Stomach discomfort or nausea
Mood or behavioural changes
Sleep disturbance
Acne or other skin changes
Seek prompt medical attention for signs of a serious infection, severe allergic reaction, significant mood or behavioural changes, severe skin rash or blistering, severe abdominal pain, or new vision problems.
This is not a complete list of side effects or warnings. Please refer to the product packaging and patient information leaflet supplied with your medicine for complete information and speak with your doctor or pharmacist if you have concerns.
Store Deflazacort according to the instructions shown on the original product packaging.
Keep the medicine in its original packaging.
Protect it from conditions that may affect the tablets, according to the product instructions.
Keep out of reach of children.
Do not use after the expiry date shown on the packaging.
Storage conditions may vary between manufacturers and product presentations.
Deflazacort 6 mg is a corticosteroid used for conditions requiring systemic corticosteroid treatment. Its approved indications vary by product and country and may include Duchenne muscular dystrophy.
The time needed to notice a therapeutic effect varies according to the condition being treated, the dose, and the individual response. Your healthcare professional can advise what to expect for the condition being treated.
Yes. Deflazacort tablets may generally be taken with or without food. Grapefruit juice should be avoided because it can affect deflazacort exposure.
Take deflazacort at the time recommended by your healthcare professional and follow the prescribed schedule consistently.
Deflazacort should not be stopped suddenly after prolonged or higher-dose treatment unless directed by a healthcare professional. Gradual dose reduction may be necessary to reduce the risk of corticosteroid withdrawal and adrenal insufficiency.
Yes. Deflazacort can suppress immune-system activity and may increase susceptibility to infections or mask some signs of infection.
Both are corticosteroids, but they are different medicines. Their doses are not directly interchangeable without appropriate medical guidance.